Why the study?
Chronic coronary syndrome was introduced to replace stable CAD to raise awareness of progressive coronary pathological changes despite clinically silent disease, prompting a review of diagnostic, risk-stratification, and management options.
Key points are not available for this paper at this time.
Design
Literature review
Answers are grounded in this paper and cite their sources.
This review summarizes the European Society of Cardiology's reclassification of stable coronary artery disease to chronic coronary syndrome, emphasizing its dynamic nature and the need for ongoing preventative management.
Chronic coronary syndrome (CCS) is a newly proposed entity by the European Society of Cardiology that replaces stable coronary artery disease (CAD), which is defined as a progressive process of plaque accumulation in coronary circulation with associated functional changes. CCS has replaced stable CAD to raise awareness that despite the clinically silent nature of the disease, there are progressive pathological changes occurring in the coronary arteries. This has allowed clinicians to review the current various diagnostic modalities, methods of risk stratifying patients based on different models and the various management options available, including lifestyle modifications, pharmacological therapies, and revascularization. With the emergence of this new entity, great emphasis has been placed on the consolidation of our comprehension of the dynamic character of the disease and the preventative actions that aim to reduce the cardiovascular disease burden.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: